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Abstract
Background and purpose: Parkinson disease (PD) is a risk
factor for dementia. In addition, specific cognitive deficits
can occur in PD patients without dementia. A patient’s lev-
el of education could have an influence on the development
of cognitive impairment in PD. The aim of this study was to
examine the relationship between the level of education and
cognitive performance in non-demented patients with PD.
Material and methods: Thirty-seven consecutive, nonde-
mented PD patients and 40 healthy controls fulfilled the
inclusion criteria and were enrolled in the case-control study.
Each of the controls and PD patients were classified, for the
purpose of this study, into one of three groups (low, interme-
diate, higher), categorized by the number of years of educa-
tion. There were no differences in education and age between
the controls and PD patients. All of the subjects were evalu-
ated with a battery of neuropsychological tests: Mini-Men-
tal State Examination, Trail Making Tests, Stroop Test, Men-
tal Rotation Test, and Verbal Fluency Test.
Results: Less (low and intermediate) education was corre-
lated with poor results from tests. The comparison of all
groups of PD patients and controls demonstrated that PD
subjects received lower test scores, especially for the low and
intermediate groups. However, no statistically significant dif-
ference was reached between educationally advanced PD
patients and the appropriate control subjects.
Conclusions: As compared to the controls, most non-dement-
ed PD patients presented executive-type cognitive dysfunc-
tion. The higher educational level, however, was associated
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St reszc zen ie
Wstêp i cel pracy: Choroba Parkinsona (ChP) jest czynni-
kiem ryzyka wyst¹pienia otêpienia, pewne zaburzenia poznaw-
cze mog¹ wystêpowaæ jednak¿e ju¿ u chorych niespe³ niaj¹cych
kryteriów demencji. Poziom wykszta³cenia mo¿e mieæ wp³yw
na obecnoœæ zaburzeñ poznawczych. Postuluje siê, ¿e niski
poziom edukacji mo¿e byæ zwi¹zany z szybszym pogorsze-
niem funkcjonowania poznawczego, a wy¿sze wykszta³cenie
mo¿e stanowiæ czynnik ochronny. Celem badañ by³a próba
ustalenia zwi¹zku pomiêdzy obecnoœci¹ zaburzeñ poznaw-
czych a poziomem wykszta³cenia u chorych na ChP bez
otêpienia.
Materia³ i metody: Przebadano 37 chorych na ChP i 40 osób
z grupy kontrolnej. Dla celów pracy badanych podzielono na
trzy podgrupy w zale¿noœci od poziomu wykszta³cenia (pod-
stawowe/zawodowe, œrednie, wy¿sze). Poszczególne podgru-
py osób badanych i kontrolnych nie ró¿ni³y siê pod wzglêdem
liczebnoœci i wieku. W obu grupach oceniono funkcjonowa-
nie poznawcze przy zastosowaniu testów psychologicznych
(Krótka Skala Oceny Stanu Psychicznego, Test £¹czenia
Punktów, Test Stroopa, Test Rotacji Figury, Test Fluencji
S³ownej).
Wyniki: Ni¿sze wykszta³cenie (podstawowe/zawodowe i œred-
nie) wi¹za³o siê z gorszymi wynikami testów psychologicz-
nych. Porównanie grupy chorych i kontrolnej wykaza³o, i¿
chorzy osi¹gaj¹ gorsze wyniki testów, w szczególnoœci chorzy
z ni¿szym wykszta³ceniem (podstawowym/zawodowym i œred-
nim) w porównaniu z osobami z grupy kontrolnej o tym
samym poziomie wykszta³cenia. Porównuj¹c chorych na ChP
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Introduction
Cognitive deficits are common in Parkinson disease
(PD), even in early stages and in newly diagnosed 
cases [1-4]. In many patients, these deficits may not be
clinically apparent, but they are detectable with specific
neuropsychological tests. According to Caviness et al.,
neuropsychological testing for abnormalities in non-
demented patients could have predictive value for the
potential development of dementia [5]. The most fre-
quent early cognitive abnormalities in PD are executive
and visuospatial dysfunction, attention and memory
impairment, and bradyphrenia [6-9].
The prevalence of dementia in PD is estimated at
a level of 24 to 31% [10,11], and longitudinal studies
show a frequency as high as 60% after 12 years of fol-
low-up [12] and even 83% in 20-year survivors [13].
With such high rates of cognitive decline, diagnostic
methods and tests that could help in identifying PD
patients at higher risk of developing dementia could
be useful in planning patient management and treat-
ment.
A number of risk factors for cognitive deterioration
and dementia in PD patients have been identified,
including the following: older age [11,12,14,15], later
age at onset [4,14], longer duration of PD [12], more
advanced motor symptoms [15] and bradykinesia-
 dominant PD with postural instability and gait difficulty
[8,15,16]. 
Recently, the positive role of education has been
described in a number of studies; the data suggest that
a more advanced educational level seems to be protec-
tive against cognitive dysfunction, while poorer edu-
cation was associated with a faster rate of cognitive
decline in nondemented patients with PD [2,6,11,15,
17-19].
The aim of this study was to assess the relationship
between the level of education and cognitive perfor-
mance in nondemented PD patients.
Material and methods
Patients
Thirty-seven consecutive PD patients admitted to
the Department of Neurology at Poznan University of
Medical Sciences were examined between January 2006
and November 2007. Patients were included in the study
on the basis of UK Parkinson’s Disease Society Brain
Bank criteria for idiopathic PD and evaluated for the
severity of symptoms using the Unified Parkinson’s 
Disease Rating Scale (UPDRS). None of the patients
fit the American Academy of Neurology (AAN) crite-
ria for having dementia in PD assessed by the Clinical
Dementia Rating (CDR) scale and the Mini-Mental
State Examination (MMSE) [20,21]. Moreover, the
subjects with depression and advanced motor symptoms
(UPDRS > 50) that impeded neuropsychological
examination were also excluded from the study.
The patients were treated with the following: levo -
dopa plus a peripheral levodopa-decarboxylase inhibitor
(37 patients), a dopamine agonist (9 patients), amanta-
dine (11 patients), an anticholinergic drug (7 patients)
and an inhibitor of monoamine oxidase B (5 patients). 
Neurologic examinations were conducted in all
patients to confirm the diagnosis of PD. Additionally,
magnetic resonance imaging (MRI) of the brain was
performed for all patients. Those with severe ischaemic
changes, defined as 3 points (white matter and/or basal
ganglia) on the Age-Related White Matter Changes
Scale, were excluded from the study [22].
Controls
The control group consisted of 40 volunteers with-
out any known neurological or vascular diseases, includ-
ing cognitive impairment and depression. 
To avoid including any subjects with detectable
abnormalities of the nervous system all control persons
with a lower risk of cognitive deterioration. We conclude that
higher education might have protective effects in cognitive
decline in PD.
Key words: Parkinson disease, cognitive impairment, educa-
tional level.
i grupê kontroln¹ z wykszta³ceniem wy¿szym, nie stwierdzo-
no znamiennych statystycznie ró¿nic dla wyników ¿adnego
z testów.
Wnioski: U osób z ChP bez otêpienia stwierdzono wystêpo-
wanie niewielkiego stopnia, ³agodnych zaburzeñ poznawczych.
Wy¿szy poziom wykszta³cenia zwi¹zany by³ z ni¿szym ryzy-
kiem wyst¹pienia zaburzeñ, dlatego mo¿e byæ czynnikiem
ochronnym dla zaburzeñ poznawczych w ChP. 
S³owa kluczowe: choroba Parkinsona, zaburzenia poznaw-
cze, poziom wykszta³cenia. 
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underwent the same neuropsychological assessment
process as PD patients.
Ethical requirements
Written informed consent was obtained from all sub-
jects after the nature of the study was fully explained.
The study was approved by the local Ethics Committee
of the University of Medical Sciences in Poznan, Poland.
Neuropsychological assessment
We used the MMSE for the assessment of global
cognitive functioning, as well as the Hamilton Depres-
sion Rating Scale (HDRS), to avoid any confounding
presence of depression in the study [23]. The HDRS
is recommended in screening for depression in PD, and,
according to Schrag et al., the cut-off level was estab-
lished at 13/14 points [24].
Specific neuropsychological tests were administered
for the assessment of executive functions, including
attention and executive and visuospatial working mem-
ory, as follows: 
• Trail Making Test (TMT), part A and B [25], Pol-
 ish translation [26],
• Stroop Test part A (reading colour names in black)
and B (naming the colour of different words; colour-
word interference effect) [27], Polish translation [26],
• Mental Rotation Test (MRT) [28],
• Verbal Fluency Test [29], for letters ‘k’, ‘m’, ‘p’ 
(an adaptation for Polish language according to
Daniluk [30]).
Overall, 12 cognitive measures were included in sta-
tistical analyses: time and numbers of errors in parts
A and B of TMT, time and number of errors in both
parts of the Stroop test, number of correct responses in
MRT (from 0 to 5), and number of words for the let-
ters ‘k’, ‘m’ and ‘p’ in the Verbal Fluency Test in one
minute. Due to the lack of normative data for Polish ver-
sions of tests assessing executive functions, the results
of neuropsychological tests of PD patients were com-
pared with the results of healthy controls. The groups
were matched for age and educational levels.
Education
The level of education of the patients and controls was
self-reported during the demographic interview and clas-
sified for the purpose of this study by the years of educa-
tion. Patients and controls were divided into 3 groups: low
(primary or vocational education: 7-11 years of education),
intermediate (secondary education: 12-13 years) or high-
er educational level (university education: 14-17 years).
Statistical analysis
The distributions of continuous variables were eval-
uated using the Kolmogorov and Smirnov method. For
each variable with a normal distribution, we calculated
the mean value and standard deviation (SD) and applied
unpaired t-tests. 
Data with non-normal distributions are provided as
geometric mean and 1 SD range. The Mann-Whitney
test and Kruskal-Wallis H-test were used for these vari-
ables to assess statistically significant differences between
the groups. The pre-established level of significance was
two-tailed at p < 0.05.
Results
Study population
Thirty-seven subjects with PD and 40 controls were
enrolled for the study. 
Clinical and demographic characteristics of the
examined subjects are shown in Table 1.
PD patients* Controls*
n = 37 n = 40
Age, years 61.03 ± 7.5, 63.22 ± 6.4, 
mean ± SD, range 46-76 46-77
Gender, male/female, 15/22 26/14
n (%) (40.5%/59.5%) (65%/35%)
Educational level, n (%)
low 10 (27.1%) 10 (25%)
intermediate 15 (40.5%) 17 (42.5%)
high 12 (32.4%0 13 (32.5%)
Age at disease onset, years 54.7 ± 6.9 –
mean ± SD
UPDRS score 28.9 ± 12.4 –
mean ± SD
Disease duration, years 6.2 ± 4.4 –
mean ± SD
MMSE score 28.7 ± 1.3 29.2 ± 0.8
mean ± SD
Table 1. Clinical and demographic characteristics of Parkinson disease (PD)
patients and control subjects
SD – standard deviation
*PD patients and control groups did not differ significantly in terms of age, time of education
and MMSE score
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The PD and control groups did not differ signifi-
cantly in terms of age, education and MMSE score.
There were some disproportions in gender between
groups; however, we did not find any differences
between males and females in terms of neuropsycho-
logical tests within the education groups.
Results of neuropsychological tests in PD patients
Significant differences were found on the basis of
educational level for the majority of tests, with the excep-
tion of the number of correct responses for the MRT.
In relation to PD patients at the higher educational 
level, the poorer-educated (low and intermediate level)
patients completed the tests more slowly and made more
errors (Table 2).
Results of neuropsychological tests in controls
Significant differences were found in terms of edu-
cational level (the lowest educational level was correlat-
ed with poorer performance on 4 measures), time of
TMT A, time of TMT B, time of Stroop A, and num-
bers of errors in TMT B (Table 3).
Comparisons between PD patients and control
subjects
Significant differences were found between PD
patients and controls. In comparison to healthy persons,
the PD patients without dementia showed worse results
on neuropsychological tests that assessed executive 
functions for 10 evaluated measures. In addition, PD
Test Educational level
Low Intermediate High
TMT A 95.80 64.26 46.50
Mean time, sec. (SD) (32.79) (27.10) (16.77)
TMT A 2.30 0.40 0.00
No. of errors, mean (SD) (3.06) (0.83) (0.00)
TMT B 257.40 151.13 102.91
Mean time, sec. (SD) (105.16) (79.37) (35.52)
TMT B 11.40 7.73 2.75 
No. of errors, mean (SD) (7.95) (6.79) (4.57)
Verbal Fluency Test K, 8.90 11.06 14.00
n, mean (SD) (2.38) (2.68) (3.49)
Verbal Fluency Test M, 5.70 9.66 11.25
n, mean (SD) (2.67) (2.99) (4.02)
Verbal Fluency Test P, 8.10 8.80 12.41
n, mean (SD) (3.51) (3.53) (4.23)
MRT, No. of correct 3.10 3.00 3.67
responses, mean (SD) (1.29) (0.65) (1.15)
STROOP A 45.00 37.00 27.17
Mean time, sec. (SD) (13.81) (12.28) (4.95)
STROOP A 3.70 3.27 1.00
No. of errors, mean (SD) (3.37) (2.31) (1.04)
STROOP B 86.90 104.87 67.08
Mean time, sec. (SD) (28.44) (38.42) (13.30)
STROOP B 3.90 0.47 0.08
No. of errors, mean (SD) (5.13) (0.92) (0.29)
Table 2. Results of neuropsychological tests in Parkinson disease (PD)
patients in different educational groups*
TMT – Trail Making Test, MRT – Mental Rotation Test 
*Significant differences (p < 0.05) are shown in bold
TMT – Trail Making Test, MRT – Mental Rotation Test 
*Significant differences (p < 0.05) are shown in bold
Test Educational level
Low Intermediate High
TMT A 56.70 35.06 44.85
Mean time, sec. (SD) (19.33) (8.45) (17.40)
TMT A 0.30 0.06 0.15
No. of errors, mean (SD) (0.67) (0.24) (0.55)
TMT B 130.00 84.70 98.31
Mean time, sec. (SD) (41.28) (23.42) (27.12)
TMT B 4.20 0.47 1.69
No. of errors, mean (SD) (5.22) (1.23) (2.69)
Verbal Fluency Test K, 13.60 14.12` 14.23
n, mean (SD) (4.15) (2.87) (3.06)
Verbal Fluency Test M, 9.70 10.53 11.77
n, mean (SD) (3.74) (1.94) (2.80)
Verbal Fluency Test P, 10.00 11.88 13.69
n, mean (SD) (4.08) (1.65) (3.64)
MRT, no. of correct 3.60 3.70 4.15
responses, mean (SD) (1.35) (0.77) (0.99)
STROOP A 33.40 25.53 25.31
Mean time, sec. (SD) (9.29) (3.41) (3.97)
STROOP A 1.10 0.59 0.38
No. of errors, mean (SD) (1.29) (0.94) (0.77)
STROOP B 77.20 64.06 62.92
Mean time, sec. (SD) (22.57) (9.29) (9.03)
STROOP B 0.40 0.06 0.15
No. of errors, mean (SD) (0.69) (0.24) (0.55)
Table 3. Results of neuropsychological tests, in controls in different educa-
tional groups*
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patients’ responses were slower and exhibited more
errors (Table 4). The less-educated (low and interme-
diate level) PD patients, compared with less-educated
controls, displayed worse results for most of the psy-
chological tests. In contrast to the lower education
groups, there were no significant differences between
test results of higher-educated PD patients and higher-
educated controls (Table 5).
Discussion
Our study shows that PD patients who did not ful-
fil standard criteria for dementia had specific cognitive
deficits in terms of visuospatial working memory, atten-
tion and verbal fluency when compared to age- and edu-
cation-matched controls without PD. Similar results
were obtained by other authors who compared patients
at earlier stages of PD with healthy subjects, in terms of
the onset of cognitive disorders [1,4,7,9]. However,
these studies found no significant differences between
groups with respect to education. In our study, the analy-
sis of the effect of education on cognitive performance
for the PD group demonstrated that higher-educated
subjects performed best on most tests, and those with
shorter education periods performed worse. Similar
effects were also noticeable in subjects without PD.
According to Spreen et al. [29], the poor education of
the general, healthy population may particularly account
for the results of the TMT and Stroop tests. In our
study, the time taken to complete the tests differed sig-
nificantly, not only in PD patients but also in control
groups. However, in the group of PD patients, the nega -
tive influence of poorer education was clearly stronger.
Significant differences between education groups are
apparent for the results of most tests (11 of 12 measures)
performed by PD patients. In the controls, significance
was achieved between education groups in only 4 out of
12 measures (time TMT A, time TMT B, time Stroop
A, numbers of errors in TMT B) (Table 2).
Lower-educated PD patients (low and intermediate
educational level) performed worse on psychological
tests compared with lower-educated controls (respec-
tively, for 7 and 9 measures). The finding that there were
no significant differences in terms of test results between
higher-educated PD persons and higher-educated con-
trols, however, suggests that more advanced education
may foster a protective effect against early cognitive
decline in PD. The positive effect of a higher educa-
tional level has also been described by Cohen et al. [17],
who compared PD patients based on education level and
reported better cognitive performance among higher-
educated patients, especially for tests assessing execu-
tive functions. A similar relationship was also affirmed
by Kandiah et al. [2] in a de novo PD group, as well as
by Green et al. [6] in patients with advanced PD. In
another study targeting the lower educational level, more
severe disease states (as assessed by UPDRS total score)
and older age at disease onset were the prominent risk
factors for dementia [18]. Additionally, in a meta-analy-
sis that included 13 longitudinal studies, lower educa-
tional levels have been found to be associated with
a greater rate of cognitive decline in PD patients [19].
From a theoretical point of view, better-educated per-
sons may have greater cognitive reserves, which could
be a protective factor against cognitive decline, especially
in the early phases of the disease.
Test PD patients Controls
TMT A 67.03 (31.84) 43.65 (16.88)
Mean time, sec. (SD)
TMT A 0.78 (1.87) 0.15 (0.48)
No. of errors, mean (SD)
TMT B 164.22 (96.62) 100.45 (34.32)
Mean time, sec. (SD)
TMT B 7.11 (7.19) 1.80 (3.38)
No. of errors, mean (SD)
verbal Fluency Test K, 11.43 (3.46) 14.03 (3.21)
N, mean, (SD)
verbal Fluency Test M, 9.11 (3.89) 10.73 (2.80)
N, mean, (SD)
Verbal Fluency Test P, 9.78 (4.11) 12.00 (3.32)
n, mean, (SD)
MRT, no. of correct 3.24 (1.04) 3.83 (1.01)
responses, mean (SD)
STROOP A 35.97 (12.76) 27.43 (6.46)
Mean time, sec. (SD)
STROOP A 2.65 (2.57) 0.65 (1.00)
No. of errors, mean (SD)
STROOP B 87.76 (33.09) 66.98 (14.63)
Mean time, sec. (SD)
STROOP B 1.27 (3.10) 0.18 (0.50)
No. of errors, mean (SD)
Table 4. Comparison of the results of neuropsychological tests between 
Parkinson disease (PD) patients and control subjects*
TMT – Trail Making Test, MRT – Mental Rotation Test
*Significant differences (p < 0.05) are shown in bold
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Cognitive and brain reserves are hypothetical constructs
that are suggested to occur in patients with Alzheimer 
disease [31,32]. However, the cognitive reserve theory
may, to some extent, help to explain the results of our study.
According to Stern [31], cognitive reserve could be defined
as ‘individual differences in how people process tasks, allow-
ing some to cope better than others with brain pathology’.
According to the same hypothesis, such a reserve theory
focuses on the process that allows individuals to sustain
brain damage and maintain function. In the cognitive
reserve construct, the are two main components: (a) neur-
al reserve: assuming that brain networks are more efficient
and have greater capacity or are more flexible in persons
with greater reserve, greater neural reserve would equate
to a larger capacity to cope with the disruption imposed by
brain pathology; and (b) neural compensation, which Stern
defined as ‘inter-individual variability in the ability to com-
pensate for the pathological disruption of standard pro-
cessing networks by using brain structures or networks not
normally used by individuals with an intact brain’ [31].
Whether one, or both, of these mechanisms is involved in
the protective effect of education, and whether the mech-
anism is influenced by working in more intellectually
demanding professions, are still open questions. 
Recently, it was shown that vascular risk factors, along
with white matter abnormalities, probably do not con-
tribute significantly to cognitive impairment in PD
patients, with the exception of PD patients with severe
cerebral ischaemic lesions [33,34]. Therefore, it is possi-
ble that pathomechanisms of cognitive decline in PD could
be different than in vascular dementia or Alzheimer dis-
ease [34,35].
Test Low Intermediate High
educational level educational level educational level
PD Controls PD Controls PD Controls
n = 10 n = 10 n = 15 n = 17 n = 12 n = 13
TMT A 95.80 (32.79) 56.70 (19.33) 64.27 (27.10) 35.06 (8.45) 46.50 (16.77) 44.85 (17.40)
Mean time, sec. (SD)
TMT A, 2.30 (3.06) 0.30 (0.67) 0.40 (0.83) 0.06 (0.24) 0.00 (0.00) 0.15 (0.55)
No. of errors, mean (SD)
TMT B 257.40 (105.16) 130.00 (41.23) 151.13 (79.37) 84.71 (23.42) 102.92 (35.53) 98.31 (27.12)
Mean time, sec. (SD)
TMT B 11.40 (7.95) 4.20 (5.22) 7.73 (6.79) 0.47 (1.23) 2.75 (4.58) 1.69 (2.69)
No. of errors, mean (SD)
Verbal Fluency Test K, 8.90 (2.38) 13.60 (4.14) 11.07 (2.69) 14.12 (2.87) 14.00 (3.49) 14.23 (3.06)
n, mean (SD)
Verbal Fluency Test M, 5.70 (2.67) 9.70 (3.74) 9.67 (2.99) 10.53 (1.94) 11.25 (4.03) 11.77 (2.80)
n, mean (SD)
Verbal Fluency Test P, 8.10 (3.51) 10.00 (4.08) 8.80 (3.53) 11.88 (1.65) 12.42 (4.23) 13.69  (3.64)
n, mean (SD)
MRT, no. of correct 3.10 (1.29) 3.60 (1.35) 3.00 (0.65) 3.71 (0.77) 3.67 (1.15) 4.15 (0.99)
responses, mean (SD)
STROOP A 45.00 (13.82) 33.40 (9.30) 37.00 (12.28) 25.53 (3.41) 27.17 (4.95) 25.31 (3.97)
Mean time, sec. (SD)
STROOP A,  3.70 (3.37) 1.10 (1.29) 3.27 (2.31) 0.59 (0.94) 1.00 (1.04) 0.38 (0.77)
No. of errors, mean (SD)
STROOP B 86.90 (28.44) 77.20 (22.57) 104.87 (38.42) 64.06 (9.29) 67.08 (13.30) 62.92 (9.03)
Mean time, sec. (SD)
STROOP B 3.90 (5.13) 0.40 (0.70) 0.47 (0.94) 0.06 (0.24) 0.08 (0.29) 0.15 (0.55)
No. of errors, mean (SD)
Table 5. Comparison of educational level for matched groups of Parkinson disease (PD) patients and controls*
TMT – Trail Making Test, MRT – Mental Rotation Test 
*Significant differences (p < 0.05) are shown in bold
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Conclusions
1. It seems probable that educational achievements may
positively affect the cognitive performance after the
onset of PD.
2. Hypothetically, protective effects of higher levels of
education, independent of dementia aetiology, may be
due to greater functional brain reserves. 
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